Androgenetic alopecia treatment market

Androgenetic Alopecia Treatment Market, by Drug Type (Topical Agents, 5 AR Inhibitors, and Others), by Route of Administration (Oral and Topical), by Gender (Male and Female), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Request Free Sample

Dec 2020
CMI4316
195 Pages
Excel & Pdf
Pharmaceutical

Summary

Androgenetic alopecia (AGA) is a patterned hair loss occurring due to systemic androgen and genetic factors. It is the most common cause of hair loss in both genders. It is characterized by follicular miniaturization in a patterned hair loss occurring due to systemic androgen and genetic factors. The increasing incidence of androgenetic alopecia is expected to boost the market growth. According to the National Center for Biotechnology Information (NCBI), in August 2015, global prevalence of severe androgenetic alopecia (AGA) was 15.33% overall and varied significantly by geographical region. The risk of having severe androgenetic alopecia (AGA) increased by 1.092 for per year for the 30 and 40 age group.

The global androgenetic alopecia treatment market is estimated to be valued at US$ 1,607.47 million in 2020 and is expected to exhibit a CAGR of 5.2% during the forecast period (2020-2027).

Figure 1. Global Androgenetic Alopecia Treatment Market Share (%), by Region, 2020

Product development and ongoing clinical trials are expected to propel growth of the global androgenetic alopecia treatment market.

Development of drugs for androgenetic alopecia treatment is expecting to boost the market growth over the forecast period. For instance, Cairo University is conducting clinical trial of topical Cetirizine for the treatment of androgenetic alopecia in females. The trial is in Phase II/III evaluating the efficacy and tolerability of topical cetirizine in female patients with androgenetic alopecia (AGA). This interventional trial started in February 2020 and the study expected completed in December 2021.

However, side effects of androgenetic alopecia treatment are expected to hinder the market growth. According to the US Pharmacist, a clinically-focused pharmacy publication, published an article- Treatment Options for Androgenetic Alopecia, in 2018 that medication used in for the treatment of androgenetic alopecia has many side effects. For example, topical Minoxidil can cause local erythema and pruritus and Finasteride can cause dizziness, orthostatic hypotension and others.

Androgenetic Alopecia Treatment Market Report Coverage

Report Coverage	Details
Base Year:	2019	Market Size in 2020:	US$ 1,607.47 Mn
Historical Data for:	2016 to 2019	Forecast Period:	2020 to 2027
Forecast Period 2020 to 2027 CAGR:	5.3%	2027 Value Projection:	US$ 2,298.34 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Drug Type: Topical Agents, 5 AR Inhibitors, Others. By Route of Administration: Oral, Topical. By Gender: Male, Female. By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Companies covered:	Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy’s Laboratories, HCell Inc., Follica, Inc. and Ranbaxy Laboratories Ltd.
Growth Drivers:	Rising incidence of androgenetic alopecia Product development and ongoing trials for treatment of androgenetic alopecia
Restraints & Challenges:	Side effects of androgenetic alopecia treatment Alternative treatment for androgenetic alopecia treatment

Figure 2. Global Androgenetic Alopecia Treatment Market Share (%), by Drug Type, 2020

Research and development of treatment for androgenetic alopecia in North America is expected to boost the market growth.

North America is expected to hold dominant position in the global androgenetic alopecia treatment market owing to research and development of treatments for androgenetic alopecia in the region. For instance, on June 4, 2020, Follica, Inc., a biotechnology company developing a regenerative platform designed to treat androgenetic alopecia, and other related conditions, announced positive feedback from the U.S. Food and Drug Administration (FDA) for its FOL-004 Phase II released in December 2019. The company advanced its lead program, FOL-004 into Phase III development, following a successful safety and efficacy optimization study for the treatment of hair loss in male androgenetic alopecia.

Global Androgenetic Alopecia Treatment Market – Impact of Coronavirus (COVID-19) Pandemic

Nationwide lockdowns resulting from COVID-19 in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare is one such sector which has been impacted significantly by the COVID-19 pandemic.

The lockdown in various countries due to the pandemic has placed an economic burden on the healthcare sector. Moreover, the coronavirus pandemic has hampered the development, production, and supply of drugs and other healthcare products and affected growth of healthcare businesses of various companies across the globe.

As a result, the impact of the COVID-19 pandemic is also expected to limit growth of the global androgenetic alopecia treatment drugs market during the forecast period.

Key Players

Major players operating in the global androgenetic alopecia treatment market are Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy’s Laboratories, HCell Inc., Follica, Inc. and Ranbaxy Laboratories Ltd. among others.

Table of Content

*Browse 40 market data tables and 35 figures on "Androgenetic Alopecia Treatment Market” - Global forecast to 2027

N/A

- Frequently Asked Questions -

What will be the compound annual growth rate (CAGR) of the market during the forecast period (2020-2027)?

The global androgenetic alopecia treatment market is expected to exhibit a CAGR of 5.2% during the forecast period (2020-2027).

What is the estimated market size of the global androgenetic alopecia treatment market in 2020?

The global androgenetic alopecia treatment market is estimated to be valued at US$ 1,607.47 million in 2020.

What are the major drivers for the global androgenetic alopecia treatment market growth?

Rising incidence of androgenetic alopecia and ongoing clinical trials for the treatment of androgenetic alopecia are favoring the market growth.

Which is the leading segment based on drug type in the global androgenetic alopecia treatment market?

The topical agents segment is expected to be the leading drug type segment in the global androgenetic alopecia treatment market during the forecast period (2020-2027).

Which region held the largest market share in the global androgenetic alopecia treatment market?

North America holds the largest market share in the global androgenetic alopecia treatment market.

Androgenetic alopecia treatment market

Androgenetic Alopecia Treatment Market Report Coverage

Table of Contents

- Frequently Asked Questions -

What will be the compound annual growth rate (CAGR) of the market during the forecast period (2020-2027)?

What is the estimated market size of the global androgenetic alopecia treatment market in 2020?

What are the major drivers for the global androgenetic alopecia treatment market growth?

Which is the leading segment based on drug type in the global androgenetic alopecia treatment market?

Which region held the largest market share in the global androgenetic alopecia treatment market?

Which are the major players operating in the global androgenetic alopecia treatment market?

Reliability and reputation

Secure Payments By: